Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab

ConclusionEarly recognition of atypical hemolytic uremic syndrome is often difficult as several other conditions also manifest as thrombotic microangiopathy during pregnancy, causing delay in initiating appropriate treatment. Our case suggests that treatment of atypical hemolytic uremic syndrome in early trimester of pregnancy with eculizumab results in good outcome to mother and fetus.
Source: Experimental Hematology and Oncology - Category: Cancer & Oncology Source Type: research